Lumida
/CRS
⌘K
Carpenter Technology Corp

Carpenter Technology Corp

CRS
$443.19USD-1.13%-5.06 today

MARKET CAP

22.0B

P/E (TTM)

46.7x

FWD P/E

DAY RANGE

$442 – $457

52W RANGE

$228
$626

AI Summary

Stalk
TrimMedium

CRS is entrenched in a Stage 4 decline, exhibiting sequential lower highs and lower lows below falling EMAs. Medium-term bias is bearish while long-term trend remains supported by a rising 200-day SMA. Short-term timing is unfavorable for fresh shorts until price rallies into EMA resistance. Executions should be trimmed into strength near key moving averages.

  • FY26 Q4 revenue of $607.4M up 11% YoY; operating income $206.9M (+37% YoY)
  • FY27 operating income guidance raised to $850M–$880M
  • GF Value™ suggests 154.5% overvaluation, pressuring future returns
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Carpenter Technology Corporation (NYSE: CRS) is a leading manufacturer of specialty alloys, including titanium and nickel-based superalloys, primarily serving critical industries such as aerospace, defense, energy, and medical sectors. The company has established a strong market position, particularly within aerospace, which is experiencing significant growth driven by rising demand for new aircraft and defense materials. Carpenter's commitment to innovation and capacity expansion positions it favorably amid current macroeconomic trends, including heightened defense spending and recovery in aviation.

Bull says

  • FY26 Q4 revenue of $607.4M up 11% YoY; operating income $206.9M (+37% YoY)
  • FY27 operating income guidance raised to $850M–$880M
  • $400M brownfield expansion on track to complete by early FY28
  • Authorized $1B buyback; executed $179M in FY26; liquidity robust
  • Aerospace bookings jumped 23% sequentially, supporting backlog strength
  • Strong profitability and momentum; moderate leverage, high growth potential

Bear says

  • GF Value™ suggests 154.5% overvaluation, pressuring future returns
  • Quality score of −1.97 highlights potential balance sheet stress
  • Medical segment sales plunged 29% YoY, indicating demand instability
  • Defense orders susceptible to geopolitical tensions and shutdown risks
  • High share volatility and negative dividend yield deter investors
  • Raw material cost swings may compress future margins

Investment themes with CRS

Defense -2.59%

Military equipment and defense contractors

BWXT · RKLB · CRS
Infrastructure Development -1.13%

DE · HWM · TT

Earnings Call · Q4 2025 · Mgmt. Guidance

Updated 08-15-2026bullish

Transcript signals

Bull points

  • we generated 151 million in adjusted operating income, a 21% increase over our fourth quarter of fiscal year 2024
  • In addition, with strong earnings and a disciplined working capital management, we generated 201.3 million in adjusted free cashflow during the quarter.
  • we generated 525.4 million in adjusted operating income, a 48% increase over fiscal year 2024, our previous record year and nearly four times our fiscal year 2023.

Bear points

  • sales excluding surcharge decreased 2% year over year on 14% lower volumes.
Read full transcript analysis ›